
Patrick Bussfeld, MD, VP, head medical affairs ophthalmology at Bayer Consumer Care AG, discusses the results from several treat-and-extend studies on aflibercept, and how Bayer is participating in the 2020 EURETINA virtual meeting.

News

Conference

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Modern Retina® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the retinal and ophthalmic communities.

EURETINA

Patrick Bussfeld, MD, VP, head medical affairs ophthalmology at Bayer Consumer Care AG, discusses the results from several treat-and-extend studies on aflibercept, and how Bayer is participating in the 2020 EURETINA virtual meeting.

Bayer discusses relevant clinical study results